Cullinan Therapeutics raised $131.2M Series C venture round, led by Foresite Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Foresite CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Investment Bank | — |
| Venture Capital | — |
| Venture Capital | — |
| Hedge Fund | — |
| Venture Capital | — |
| Private | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$379.7M
Top Valuation
-
Cullinan Therapeutics raised $131.2M in a Series C round.
The round was announced on 12/17/20.
The round was led by Foresite Capital.